Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.
about
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced cancers of the gastrointestinal tract or anus.Circulating tumor DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer.Tumour heterogeneity and resistance to cancer therapies.Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma.Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
P2860
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Clinical utility of circulatin ...... ients for anti-EGFR treatment.
@en
Clinical utility of circulatin ...... ients for anti-EGFR treatment.
@nl
type
label
Clinical utility of circulatin ...... ients for anti-EGFR treatment.
@en
Clinical utility of circulatin ...... ients for anti-EGFR treatment.
@nl
prefLabel
Clinical utility of circulatin ...... ients for anti-EGFR treatment.
@en
Clinical utility of circulatin ...... ients for anti-EGFR treatment.
@nl
P2093
P2860
P356
P1433
P1476
Clinical utility of circulatin ...... tients for anti-EGFR treatment
@en
P2093
A R Thierry
B Auzemery
C Gavoille
P2860
P304
P356
10.1093/ANNONC/MDX330
P577
2017-09-01T00:00:00Z